Keefe Bruyette lowered the firm’s price target on MetLife (MET) to $98 from $100 and keeps an Outperform rating on the shares.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET:
- MetLife price target lowered to $95 from $96 at Barclays
- MetLife Reports Strong 2024 Earnings Growth
- MetLife Earnings Call: Positive Outlook Amid Challenges
- Optimistic Outlook: MetLife’s Strong Recovery and Future Growth Potential Supports Buy Rating
- Positive Outlook for MetLife Stock Amid Strategic Share Repurchases and Improved Investment Income